Small Differences in Weight Change With First-Line Antidepressants

2024-07-01
MONDAY, July 1, 2024 -- For eight first-line antidepressants, small differences are seen in mean weight change, with the least weight gain with bupropion, according to a study published online July 2 in the Annals of Internal Medicine.
Joshua Petimar, Sc.D., from Harvard Medical School and Harvard Pilgrim Health Care Institute in Boston, and colleagues conducted an observational cohort study over 24 months to compare weight change across common first-line antidepressant treatments using electronic health record data for 183,118 patients. Initiation of treatment with sertraline, citalopram, escitalopram, fluoxetine, paroxetine, bupropion, duloxetine, or venlafaxine was ascertained using prescription data.
The researchers found that the estimated six-month weight gain was higher for escitalopram, paroxetine, duloxetine, venlafaxine, and citalopram than sertraline (differences, 0.41, 0.37, 0.34, 0.17, and 0.12 kg, respectively), was similar for fluoxetine (difference, −0.07 kg), and was lower for bupropion (difference, −0.22 kg). A 10 to 15 percent higher risk for gaining at least 5 percent of baseline weight was seen for escitalopram, paroxetine, and duloxetine, while a 15 percent reduced risk was seen for bupropion. Associations were stronger, with wider confidence intervals, when the effects of initiation and adherence were estimated. There was variation seen in six-month adherence, from 28 to 42 percent for duloxetine and bupropion, respectively.
"Clinicians and patients could consider these differences when making decisions about specific antidepressants, especially given the complex relationships of obesity and depression with health, quality of life, and stigma," the authors write.
Abstract/Full Text (subscription or payment may be required)
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.
更多内容,请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点,如有版权侵扰或错误之处,请及时联系我们,我们会在24小时内配合处理。
机构
适应症
靶点
-
药物
[+5]
来和芽仔聊天吧
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台,助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台,以API或者数据包形式对外开放,助您更加充分利用智慧芽新药情报信息。